Skip to main content
. 1998 Jan;42(1):121–128. doi: 10.1128/aac.42.1.121

TABLE 5.

Susceptibility patterns of S. aureus MT5 gyrB142 strains diploid for grlB+ and mutant grlBa

Strain/plasmid Type of grlBb in:
Plasmid positionc MIC (μg/ml)d
Chromosome Plasmid CPFX NFLX OFLX SPFX NA OA NOV COU
MT5/pSK950 Wild None Plasmid 0.125 0.5 0.25 0.06 128.0 4.0 40.0 5.0
MT5/pBFC9B Wild N470D Plasmid 1.0 4.0 1.0 0.12 128.0 2.0 10.0 1.25
MT5224c9/pSK950 N470D None Plasmid 1.0 8.0 1.0 0.12 128.0 4.0 5.0 1.25
MT5224c9/pBFISB N470D Wild Plasmid 0.125 0.25 0.25 0.06 128.0 4.0 40.0 5.0
MT5/pSK950 Wild None Chromo. 0.125 0.25 0.25 NDe ND ND 40.0 5.0
MT5/pBFC9B Wild N470D Chromo. 0.5 1.0 0.5 ND ND ND 20.0 5.0
MT5224c9/pSK950 N470D None Chromo. 1.0 4.0 1.0 ND ND ND 2.5 0.62
MT5224c9/pBFISB N470D Wild Chromo. 0.25 1.0 0.5 ND ND ND 40.0 5.0
a

MT5 and MT5224c9 carry a double mutation of gyrB (Ile102Ser and Arg144Ile). 

b

Wild, wild-type gene; none, plasmid vector only; N470D, mutant gene (grlB543) encoding Asn470Asp mutation. 

c

Position of the plasmid: free in the cell (plasmid) or integrated in the chromosome (chromo.). 

d

CPFX, ciprofloxacin; NFLX; norfloxacin; OFLX, ofloxacin; SPFX, sparfloxacin; NA, nalidixic acid; OA, oxolinic acid; NOV, novobiocin; COU, coumermycin. The MICs are the means of three different transformants. 

e

ND, not determined.